Table of contents
March 2005 Volume 2 No 3
Top of page
Editorial
Top of page
Viewpoint
Top of page
Research Highlights
Sildenafil therapy for erectile dysfunction in peritoneal dialysis patients
116CD59 could provide a diagnostic clue to prostate cancer prognosis
116Overactive bladder syndrome: effect of continence status
118Simplifed procedure for sperm extraction under magnification
119High vitamin B12 and folate increase prostate cancer risk
119On-the-spot test for bladder cancer superior to urinary cytology
120Chlorambucil and lomustine (CL56) to treat androgen-independent prostate cancer
121A guide to grant writing for the clinical researcher
121EphA2 expression predicts outcome in patients with renal cell carcinoma
121Defining risk in patients with renal cell carcinoma
122Top of page
Practice Points
Does preservation of the neurovascular bundle affect surgical outcome in men with prostate cancer?
124Can a noninvasive penile-cuff test predict bladder outlet obstruction?
126Can self-directed pelvic floor exercises improve erectile function?
128Can ultrasound measurement of residual bladder volume be improved with a novel, personalized algorithm?
130Does slower delivery of shock-wave lithotripsy improve treatment efficacy for urolithiasis?
132
B predictive of biochemical recurrence in positive-margin prostate cancer?Top of page
Reviews
Active surveillance with selective delayed intervention is the way to manage 'good-risk' prostate cancer
136With the increase in prevalence of prostate cancer following the introduction of PSA screening, most cancers are now detected at an early stage. In patients with 'good-risk' prostate cancer there is a risk of overtreatment, but it is important that this should be balanced with the possibility of undertreating those at risk of disease progression.
doi:10.1038/ncpuro0124 | Full Text | PDF (125K)
Technology Insight: applications of tissue engineering and biological substitutes in urology
143doi:10.1038/ncpuro0121 | Full Text | PDF (380K)
